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Clinical PerspectiveWhat Is New?Fine particulate matter exposure causes hypertension because of the dysfunction of the renal dopamine D~1~ receptor.Increased oxidative stress, associated with increased G‐protein--coupled receptor kinase type 4 levels, impairs renal D~1~ receptor function and leads to hypertension.What Are the Clinical Implications?Particulate matter air pollution might play an important role in the pathogenesis of hypertension.Restoration of dopamine D~1~ receptor function by antioxidants may be a therapeutic target for fine particulate matter--caused hypertension.

 {#jah32865-sec-0008}

Epidemiological evidence supports an important association between air pollution exposure and cardiovascular risks.[1](#jah32865-bib-0001){ref-type="ref"} The World Health Organization reported that \>800 000 premature deaths worldwide per year can be directly attributed to particulate matter air pollution.[2](#jah32865-bib-0002){ref-type="ref"} The ESCAPE (European Study of Cohorts for Air Pollution Effects) showed that a 5 μg/m^3^ increase in estimated annual mean fine particulate matter (PM~2.5~) was associated with a 13% increased risk of coronary events.[3](#jah32865-bib-0003){ref-type="ref"} Recently, the relationship between particulate matter and hypertension is getting more and more attention.[4](#jah32865-bib-0004){ref-type="ref"} Dai‐Hua Tsai *et al* found that inhalable particulate matter short time exposure, a 10 μg/m^3^ increase in inhalable particulate matter level, is associated with higher nighttime blood pressure and is preceded by associations with the reduced ability of the kidney to excrete sodium during the daytime.[5](#jah32865-bib-0005){ref-type="ref"} Numerous investigations have shown that exposure to PM~2.5~ elucidated potential biological consequences, such as modulation of blood pressure, including systemic proinflammatory oxidative responses, DNA damage, and autonomic nervous system imbalance.[5](#jah32865-bib-0005){ref-type="ref"}, [6](#jah32865-bib-0006){ref-type="ref"}, [7](#jah32865-bib-0007){ref-type="ref"}, [8](#jah32865-bib-0008){ref-type="ref"}, [9](#jah32865-bib-0009){ref-type="ref"}, [10](#jah32865-bib-0010){ref-type="ref"}, [11](#jah32865-bib-0011){ref-type="ref"}, [12](#jah32865-bib-0012){ref-type="ref"} However, the underlying pathophysiological mechanisms of airborne PM~2.5~‐mediated hypertension are complex and remain to a large extent unexplored. Studies have shown that hypertension is caused by prohypertensive factors, which include the increased activity of the sympathetic nervous system and the decreased activity of antihypertensive mechanisms, such as sodium excretion.[13](#jah32865-bib-0013){ref-type="ref"} The kidney is endowed with local hormonal systems that play major roles in the regulation of sodium transport across the renal proximal tubule (RPT).[14](#jah32865-bib-0014){ref-type="ref"} Among those systems, dopamine is taken as an important one, which is synthesized in and secreted from RPT cells and decreases RPT sodium transport,[13](#jah32865-bib-0013){ref-type="ref"}, [14](#jah32865-bib-0014){ref-type="ref"}, [15](#jah32865-bib-0015){ref-type="ref"}, [16](#jah32865-bib-0016){ref-type="ref"}, [17](#jah32865-bib-0017){ref-type="ref"} via the D~1~ and D~3~ receptors, by inhibition of NHE3 at the brush border membrane and Na^+^‐K^+^‐ATPase at the basolateral membrane.[13](#jah32865-bib-0013){ref-type="ref"} In hypertensive states, the renal D~1~ receptor is hyperphosphorylated, which leads to its dysfunction, and is ascribed to the higher G‐protein--coupled receptor kinase type 4 (GRK4) expression[13](#jah32865-bib-0013){ref-type="ref"}, [18](#jah32865-bib-0018){ref-type="ref"} and activity in spontaneously hypertensive rats or hypertensive patients.[19](#jah32865-bib-0019){ref-type="ref"}, [20](#jah32865-bib-0020){ref-type="ref"}, [21](#jah32865-bib-0021){ref-type="ref"} This can be linked to increased oxidative stress.[22](#jah32865-bib-0022){ref-type="ref"}, [23](#jah32865-bib-0023){ref-type="ref"}, [24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"} Many studies have shown that the impaired intrarenal D~1~ receptor signaling in hypertension can cause or be caused by oxidative stress.[24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"}, [26](#jah32865-bib-0026){ref-type="ref"}, [27](#jah32865-bib-0027){ref-type="ref"} Antioxidant supplementation with tempol (4‐hydroxy‐2,2,6,6‐tetramethylpiperidin‐1‐oxyl), a superoxide dismutase (SOD) mimetic, decreases oxidative stress, restores D~1~ receptor signaling, and lowers blood pressure.[24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"}

There are reports that PM~2.5~ induces hypertension through impaired sodium excretion and increased reactive oxygen species (ROS) and oxidative stress[28](#jah32865-bib-0028){ref-type="ref"}, [29](#jah32865-bib-0029){ref-type="ref"}, [30](#jah32865-bib-0030){ref-type="ref"}, [31](#jah32865-bib-0031){ref-type="ref"}; ROS has been reported to decrease dopamine receptors in animals.[24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"}, [26](#jah32865-bib-0026){ref-type="ref"}, [27](#jah32865-bib-0027){ref-type="ref"} Therefore, we hypothesize that PM~2.5~, via increased ROS levels, increases GRK4 expression and consequently impairs renal D~1~ receptor function, and leads to hypertension. To test this hypothesis, we exposed Sprague‐Dawley (SD) rats to PM~2.5~ in vivo. Concurrently, we also exposed immortalized RPT cells in vitro, because they behave similarly to freshly obtained RPT cells, at least with regard to dopamine receptors and its responses to G‐protein stimulation, in this present study.

Methods {#jah32865-sec-0009}
=======

The data, analytic methods, and study materials will be made available on request to other researchers for purposes of reproducing the results or replicating the procedure.

PM~2.5~ Sampling {#jah32865-sec-0010}
----------------

The sample site was the Daping Hospital, which is ≈1 km from the city center. The nearest main road is in the northeast at a distance of 100 m. Within an ≈200 m radius of the monitoring site is almost completely surrounded by residential areas.

We used a medium volume sampler (model TH‐150; Tianhong Co, Wuhan, China) equipped with a PM~2.5~ filtration system to collect PM~2.5~ samples on filters (diameter, 150 mm), according to the reported method.[32](#jah32865-bib-0032){ref-type="ref"}, [33](#jah32865-bib-0033){ref-type="ref"}, [34](#jah32865-bib-0034){ref-type="ref"} The flow rate of medium volume sampler was adjusted to 30 m^3^/h. After sampling, filters were shredded into small pieces and sonicated using an ultrasonator (KQ‐250DE; Shumei, Kunshan, Jiangsu, China) for 3× 40 minutes in double‐distilled water. The extracted material was frozen, concentrated using lyophilization, and weighed to determine the extraction efficiency. The farinose solid was stored at −80°C until further use. The sampling period started on April 8, 2013, and ended on July 28, 2013. A total of 25 filters were used to collect the PM~2.5~ samples. To make sure the PM~2.5~ sample diameter was correct, we performed a scanning electron microscope analysis of the samples to prove the purity of the samples. The analysis confirmed that the particulate matter collected had a diameter of = or \<2.5 μm (Figure [S1](#jah32865-sup-0001){ref-type="supplementary-material"}).

Animal Treatment {#jah32865-sec-0011}
----------------

Male SD rats, 8 to 10 weeks old and initially weighing 198±6 g, were given a standard laboratory chow and ad libitum access to clean drinking water. They were randomly divided into 3 groups (n=56 for control, n=32 for lower dosage PM~2.5~ treatment, and n=56 for higher dosage PM~2.5~ treatment). The details of each group are shown in Figure [S2](#jah32865-sup-0001){ref-type="supplementary-material"}. The rats were individually housed in metabolic cages for urine collection and maintained at a temperature of 25±2°C, a relative humidity of 50% to 60%, and a 12‐hour dark‐light cycle. An acclimatization period of 2 days was allowed for the rats before the start of the experiments. The rats were weighed at the beginning of the experiment and just before urine collection and euthanasia. This study was approved by the Third Military Medical University Animal Use and Care Committee. All experiments conformed to the guidelines of the ethical use of animals, and all efforts were made to minimize animal suffering.

PM~2.5~ was suspended in PBS. To minimize aggregation, particle suspensions were always sonicated for 15 minutes, 3 times, and vortexed before their dilution and before intratracheal administration. Control animals received PBS treatments. The animals were anesthetized with isoflurane and placed supine with extended necks on an angled board.[33](#jah32865-bib-0033){ref-type="ref"}, [35](#jah32865-bib-0035){ref-type="ref"}, [36](#jah32865-bib-0036){ref-type="ref"} An oropharynx instillation of the PM~2.5~ suspension (3 or 30 μg PM~2.5~ in 25 μL) or PBS only was instilled (25 μL) via a sterile syringe. SD rats were treated with the PM~2.5~ solution every 3 days, for 8 weeks. In the present study, 2 dosages of PM~2.5~ treatment of either lower or higher dose were used. The lower dosage given (3 μg PM~2.5~) represented 35 μg/m^3^ per 24 hours PM~2.5~ in the air and was marked as PM~2.5~‐L. The higher dosage given (30 μg PM~2.5~) represented 350 μg/m^3^ per 24 hours PM~2.5~ in the air and marked as PM~2.5~‐H. To confirm the success of the exposure model, we performed a hematoxylin‐eosin stain of the lung after the rats were euthanized (Figure [S3](#jah32865-sup-0001){ref-type="supplementary-material"}). Light microscope detection found the PM~2.5~ in the lung tissue.

The blood pressure and 24‐hour urine volume and sodium excretion were measured in conscious rats on the indicated exposure time points. After 8 weeks of being exposed to PM~2.5~‐L, PM~2.5~‐H, and PBS, treated rats were randomly assigned into 2 groups: one group that drank tap water served as a control, and the other group drank tap water with 1.0 mmol/L tempol that was changed 2 times per day, for 3 weeks (n=12 in each group).

Blood Pressure and Urine Collection {#jah32865-sec-0012}
-----------------------------------

Systolic blood pressure, diastolic blood pressure, and mean arterial blood pressure were measured every week using a computerized, noninvasive, tail‐cuff plethysmography system in conscious rats (BP‐98A; Softron, Tokyo, Japan). The animals were individually restrained in a clear acrylic restrainer at an ambient temperature of 37°C to 38°C for 15 minutes. Five blood pressure values were recorded per rat, and the average was taken. To ensure the reliability of the measurements, a training period of 1 week was established before the start of the experiment for the rats to adapt to the method. Blood pressure measurements were performed between 3 and 5 [pm]{.smallcaps}.

SD rats were acclimated in metabolic cages for at least 2 days before urine was collected for 24 hours every week. After urine collection, sodium and potassium concentrations in urine samples were measured using a flame photometer 480 (Ciba Corning Diagnostics, Norwood, MA).

Cell Culture and Sample Preparation {#jah32865-sec-0013}
-----------------------------------

Immortalized RPT cells from microdissected S~l~ segments of the RPTs from 4‐ to 8‐week‐old Wistar‐Kyoto rats were cultured at 37°C in 95% air/5% CO~2~ atmosphere in DMEM/F‐12 with transferrin (5 μg/mL), insulin (5 μg/mL), epidermal growth factor (10 ng/mL), dexamethasone (4 μg/mL), and 5% fetal bovine serum on a 100‐mm Petri dish. The final concentration of PM~2.5~ (1--200 µg/mL) was mixed evenly into the culture medium, 24 hours prior for the PM~2.5~ exposure group, and an equal volume of PBS was mixed into the culture medium for the control group. Cells were made quiescent by incubating for 2 hours in the media without fetal bovine serum before adding the drugs. The cells (80% confluence) were extracted in ice‐cold lysis buffer, sonicated, kept on ice for 1 hour, and centrifuged at 16 000*g* for 30 minutes. All samples were stored at −80°C until use.

Immunoblotting {#jah32865-sec-0014}
--------------

In the in vivo study, immediately after euthanasia (or after thawing), the renal cortex (upper pole, left kidney) was homogenized in buffer (10 mmol/L Tris‐HCl, 250 mmol/L sucrose, 2 mmol/L phenylmethylsulfonyl fluoride, and protease inhibitor cocktail; pH 7.4) and centrifuged at 24 000*g* for 25 minutes at 4°C. The upper fluffy layer of the pellet, which is considered as the membrane fraction, was resuspended in the homogenization buffer.[37](#jah32865-bib-0037){ref-type="ref"}, [38](#jah32865-bib-0038){ref-type="ref"} The samples were quickly frozen and stored at −80°C until use. For the in vitro study, the RPT cells were lysed in a lysis buffer, sonicated, placed on ice for 1 hour, and centrifuged at 16 000*g* for 30 minutes. The supernatant was stored at −80°C until use.

After boiling the homogenates in sample buffer (35 mmol/L Tris‐HCl, pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01% bromophenol blue, and 30% glycerol) at 95°C for 5 minutes, 50 μg of protein was separated by SDS‐PAGE (10% polyacrylamide) and then electroblotted onto nitrocellulose membranes (Amersham Life Science, Arlington, TX). The blots representing the nonspecific antibodies were blocked overnight with 5% nonfat dry milk in PBS with Tween 20 (0.05% Tween 20 in 10 mmol/L PBS \[isotonic\]) at 4°C under constant shaking, then incubated with polyclonal rabbit anti‐rat GRK4 receptor antibodies (1:400; Santa Cruz Biotechnology, Santa Cruz, CA), overnight at 4°C. The other antibodies were anti‐D~1~ dopamine receptor antibody (1:400; Millipore, Billerica, MA), anti--c‐Myc (phosphorylated T58+S62) antibody (1:400; Abcam, Cambridge, UK), and rabbit polyclonal GAPDH (1:500; Santa Cruz Biotechnology). The membranes were then further incubated using infrared‐labeled secondary antibodies (donkey anti‐rabbit IRDye 800; Li‐Cor Biosciences, Lincoln, NE) to bind to the primary antibody at room temperature for 1 hour. The membranes were washed 3 times in PBS with Tween 20. The bound complex was detected using the Odyssey Infrared Imaging System (Li‐Cor Biosciences). The images were analyzed using the Odyssey Application Software to obtain the integrated intensities.

Determination of D~1~ Receptor Phosphorylation by Coimmunoprecipitation {#jah32865-sec-0015}
-----------------------------------------------------------------------

Equal amounts of lysates (1.0 μg protein/mL supernatant from RPT cells or renal cortex membranes) were incubated with dopamine D~1~ receptor (D~1~R) antibody (2 μg; Millipore) for 2 hours, followed by protein A/G agarose overnight, with constant rocking at 4°C for 12 hours. The immunoprecipitates were pelleted and washed 3 times with PBS. Then, the pellets were suspended in sample buffer, boiled for 10 minutes, and subjected to immunoblotting with phosphoserine antibody (1:400; Immunechem, Burnaby, BC, Canada). To determine the specificity of the bands, normal rabbit IgG (negative control) and D~1~ receptor antibody (positive control) were used as the immunoprecipitants. The bound complexes were detected using the Odyssey Infrared Imaging System (Li‐Cor Biosciences). Band density of the serine‐phosphorylated D~1~R was normalized by band density of D~1~R. All the bands were quantified by densitometry.

Small‐Interfering RNA {#jah32865-sec-0016}
---------------------

Small‐interfering RNA (siRNA) against GRK4 mRNA and its control, scrambled RNA, was synthesized and purified with reverse‐phased high‐performance liquid chromatography as 25‐mer phosphorothioate‐modified oligodeoxynucleotides (GRK4 siRNA sequence, 5′‐AUCUAAAGAGGUGCAUUGAAUUCUUdTdT‐3′; scrambled RNA sequence, 5′‐TGACGATAAGAACAATAACdTdT‐3′), from nucleotides 412 to 436 and 1752 to 1776, respectively, of the rat GRK4 cDNA. The effects of 50 nmol/L siRNA was compared with scrambled RNA (control). Briefly, cells were grown in 6‐well plates until 60% confluence, and 50 nmol/L siRNA or control RNA was mixed with 6 μL of Oligofectamine in Optimem medium (Invitrogen Life Technologies) and incubated for 24 hours, then switched to growth medium and incubated for another 24 hours. The cells were collected and processed for reverse transcription--polymerase chain reaction for GRK4 to determine the efficiency of siRNA‐induced GRK4 gene silencing.

Cell Counting Kit‐8 Assay {#jah32865-sec-0017}
-------------------------

As previously described,[39](#jah32865-bib-0039){ref-type="ref"} the number of viable cells was assayed using the Cell Counting Kit‐8 (Dojindo Laboratories, Kumamoto, Japan), per the manufacturer\'s protocol. Briefly, RPT cells were plated into a 96‐well plate and incubated with Cell Counting Kit‐8 for 2 hours at 37°C. The optical density (OD) values were subsequently measured on a spectrophotometer (PerkinElmer) at 490 nm. Three independent experiments were performed.

Real‐Time Quantitative Polymerase Chain Reaction Detecting System {#jah32865-sec-0018}
-----------------------------------------------------------------

A total of 2 to 3 μg of total RNA extracted from RPT cells or renal cortex membranes was used to synthesize cDNA, which served as template for the amplification of receptor and GAPDH (as the reference housekeeping gene). For GAPDH, the forward primer was 5′‐GACATGCCGCCTGGAGAAAC‐3′ and the reverse primer was 5′‐AGCCCAGGATGCCCTTTAGT‐3′ (GeneBank Accession No. NM_022928.1). For GRK4, the forward primer was 5′‐ACTTCAGCAGACTGGAAGCA‐3′ and the reverse primer was 5′‐GGTGTCCAGGTTGACTCCTT‐3′ (GeneBank Accession No. NM_017008.4). For c‐Myc, the forward primer was 5′‐ ACTTCAGCAGACTGGAAGCA‐3′ and the reverse primer was 5′‐GGTGTCCAGGTTGACTCCTT‐3′ (GeneBank Accession No. AY679730.1). The amplification was performed with the following conditions: denaturation at 95°C for 3 minutes, followed by 35 cycles at 95°C for 10 seconds and 60°C for 30 seconds. At the end of each run, a melting curve analysis was performed from 65°C to 95°C to monitor primer dimers or nonspecific product formation. The reactions were performed in triplicate. The GRK4 and c‐Myc mRNA expression was normalized for GAPDH mRNA.

Na^+^‐K^+^‐ATPase Activity Assay {#jah32865-sec-0019}
--------------------------------

Na^+^‐K^+^‐ATPase activity was determined as the rate of inorganic phosphate released in the presence or absence of ouabain.[40](#jah32865-bib-0040){ref-type="ref"}, [41](#jah32865-bib-0041){ref-type="ref"} Rat RPT cells were treated with vehicle (distilled water) and D~1~ receptor agonist,fenoldopam, at the indicated concentrations and durations of incubation. To prepare membranes for Na^+^‐K^+^‐ATPase activity assay, RPT cells cultured in 21‐cm^2^ plastic culture dishes were collected and centrifuged at 3000*g* for 10 minutes. The cells were then placed on ice and lysed in 2 mL of lysis buffer (1 mmol/L NaHCO~3~, 2 mmol/L CaCl~2~, and 5 mmol/L MgCl~2~). Cellular lysates were centrifuged at 3000*g* for 2 minutes to remove intact cells, debris, and nuclei. The resulting supernatant was suspended in an equal volume of 1 mol/L sodium iodide, and the mixture was centrifuged at 48 000*g* for 25 minutes. The pellet (membrane fraction) was washed 2 times and suspended in 10 mmol/L Tris containing 1 mmol/L EDTA (pH 7.4). Protein concentrations were determined by the Bradford assay (Bio‐Rad Laboratories, Hercules, CA) and adjusted to 1 mg/mL. The membranes were stored at −70°C until use.

To measure Na^+^‐K^+^‐ATPase activity, 100‐μL aliquots of membrane fraction were added to an 800‐μL reaction mixture (75 mmol/L NaCl, 5 mmol/L KCl, 5 mmol/L MgCl~2~, 6 mmol/L sodium azide, 1 mmol/L Na~4~EGTA, 37.5 mmol/L imidazole, 75 mmol/L Tris‐HCl, and 30 mmol/L histidine; pH 7.4), with or without 1 mmol/L ouabain (final volume=1 mL), and preincubated for 5 minutes in a water bath at 37°C. Reactions were initiated by adding Tris‐ATP (4 mmol/L) and terminated after 15 minutes of incubation at 37°C by adding 50 μL of 50% trichloroacetate. For determination of ouabain‐insensitive ATPase activity, NaCl and KCl were omitted from the reaction mixtures containing ouabain. To quantify the amount of phosphate produced, 1 mL of coloring reagent (10% ammonium molybdate in 10N sulfuric acid and 10N ferrous sulfate mix buffer) was added to the reaction mixture. The mixture was then mixed thoroughly and centrifuged at 3000*g* for 10 minutes. Formation of phosphomolybdate was determined spectrophotometrically at 740 nm, against a standard curve prepared from K~2~HPO~4~. Na^+^‐K^+^‐ATPase activity was estimated as the difference between total and ouabain‐insensitive ATPase activity and expressed as percentage change of control.

To eliminate the effect of proteases and phosphatases, protease inhibitors (1 mmol/L phenylmethylsulfonyl fluoride and 10 μg/mL each leupeptin and aprotinin) and a phosphatase inhibitor (50 μmol/L sodium orthovanadate) were added in all solutions used after drug/vehicle incubations.

Fenoldopam‐Induced Diuresis and Natriuresis {#jah32865-sec-0020}
-------------------------------------------

Twelve rats were selected from each group randomly and used for fenoldopam infusion study. A total of 36 rats from control, PM~2.5~‐L, and PM~2.5~‐H groups were anesthetized with pentobarbital (50 mg/kg IP), placed on a heated board to maintain body temperature at 37°C, and tracheotomized (PE‐100). Catheters (PE‐50) were placed into the external jugular and femoral veins and left carotid artery for fluid administration and blood pressure monitoring. Systemic blood pressure was monitored electronically using Cardiomax II (Columbus Instruments, Columbus, OH). Laparotomy was performed to expose the left and right ureters, which were then separately catheterized for urine collection. The right suprarenal artery (which originates from the right renal artery) was located and catheterized (PE‐10; heat stretched to 180 μm). After a 60‐minute stabilization period, a normal saline load equivalent to 5% of body weight was infused intravenously for 30 minutes. After the short‐term saline load, a 60‐minute stabilization period was allowed before starting the urine collection.[37](#jah32865-bib-0037){ref-type="ref"}

Five consecutive 40‐minute urine samples were collected: Vehicle was given during the first collection period (control). In the next 3 periods, the mice received fenoldopam, a D~1~‐like receptor agonist, at 3 different dose rates of 0.1, 0.5, and1 μg/kg per minute, each dose that has been shown not to affect blood pressure in previous studies.[30](#jah32865-bib-0030){ref-type="ref"}, [31](#jah32865-bib-0031){ref-type="ref"} During the last collection period (recovery), only the vehicle, normal saline, was infused. This was considered as the recovery phase of the experiment. The change in all infusates (vehicle and reagents) was commenced 10 minute before each period to account for the dead space in the delivery catheter. All infusions (vehicle and reagents) were given at a rate of 40 μL/h. Fluid losses throughout the experiment were replaced intravenously with 5% albumin at 1% body weight over 30 minutes. The rats were euthanized with an overdose of pentobarbital (100 mg/kg) at the end of the experiment right after the last sample was collected. Urine samples were stored at −80°C until use.

Biochemical Markers of Oxidative Stress {#jah32865-sec-0021}
---------------------------------------

To assess total oxidative stress, plasma samples from rats were used to measure SOD activity using an SOD Assay Kit (Dojindo Laboratories), following the manufacturer\'s instructions. Malondialdehyde and glutathione peroxidase in the plasma were quantified using a commercially available kit (Nanjing Jianchen Bioengineering Institute, Nanjing, China). For in vitro study, the RPT cell culture medium supernatants were collected to determine SOD, glutathione peroxidase, and malondialdehyde levels.

Statistical Analysis {#jah32865-sec-0022}
--------------------

The data are expressed as mean±SEM. A repeated‐measures ANOVA (dosages of PM~2.5~×time points) was used to determine the differences of blood pressure, among 3 groups (control, PM~2.5~‐L, and PM~2.5~‐H) at 0, 2, 4, 6, and 8 weeks. To analyze the effect of fenoldopam infusion on urine flow and urinary sodium excretion in different dosages of PM~2.5~‐treated groups (control, PM~2.5~‐L, and PM~2.5~‐H), another repeated‐measures (dosages of PM~2.5~×infusion periods) ANOVA was used. Dosages of PM~2.5~ were the predictor in these analyses. The Mauchly test of sphericity was performed using Greenhouse‐Geisser adjustment. Moreover, to determine the difference between groups that have been split on 2 dependent variables (whether fenoldopam treatment in cells and the dosage of PM~2.5~ \[0, 10, and 100 μg/mL\]) and their interaction, the 2‐way ANOVA was also performed. Besides, other comparisons among groups (or *t* test when only 2 groups were compared) was made by 1‐way ANOVA with Holm‐Sidak test. Post hoc multiple comparisons were performed by least significant difference method. *P\<*0.05 was considered significant.

Results {#jah32865-sec-0023}
=======

Effects of PM~2.5~ Exposure on Blood Pressure and D~1~ Receptor--Mediated Sodium Excretion in SD Rats {#jah32865-sec-0024}
-----------------------------------------------------------------------------------------------------

Long‐term exposure to PM~2.5~ caused a significant increase in both systolic and diastolic blood pressures, which were measured by the tail‐cuff method, whether by the high dose (PM~2.5~‐H) or lower dose (PM~2.5~‐L) of PM~2.5~ (Figure [1](#jah32865-fig-0001){ref-type="fig"}A and [1](#jah32865-fig-0001){ref-type="fig"}B). The differences in blood pressure between the control and PM~2.5~‐treated rats progressively increased with time (Figure [1](#jah32865-fig-0001){ref-type="fig"}A and [1](#jah32865-fig-0001){ref-type="fig"}B). The high blood pressure might be ascribed to impaired sodium excretion, because the basal levels of sodium excretion were lower in PM~2.5~‐treated SD rats. Moreover, the higher dose of PM~2.5~ decreased the sodium excretion to a greater degree compared with the lower dose (Figure [1](#jah32865-fig-0001){ref-type="fig"}C and [1](#jah32865-fig-0001){ref-type="fig"}D).

![Effect of fine particulate matter (PM ~2.5~) exposure on blood pressure and sodium excretion in Sprague‐Dawley (SD) rats. A and B, Effect of PM ~2.5~ exposure on blood pressure. SD rats received lower (3 μg PM ~2.5~ per time \[PM ~2.5~‐L\]) or higher (30 μg PM ~2.5~ per time \[PM ~2.5~‐H\]) dosage of PM ~2.5~. Systolic blood pressure (SBP) (A) and diastolic blood pressure (DBP) (B) were recorded by the tail‐cuff method (n=12 in each group). C and D, Effect of PM ~2.5~ exposure on urine volume (C) and urine sodium excretion (D) in SD rats. Urine was collected in SD rats after exposure with PM ~2.5~ or vehicle for 8 weeks (n=20 in each group). E and F, Effect of PM ~2.5~ exposure on renal dopamine D~1~ receptor (D~1~R) function in SD rats. Varying dosages of the D~1~‐like receptor agonist, fenoldopam (0.1, 0.5, and 1.0 μg/kg per minute), were infused into the right suprarenal artery in SD rats after 8‐week exposure with PM ~2.5~ or vehicle. The fenoldopam‐associated urine volume (E) and urine sodium excretion (F) were measured (n=12 in each group). G and H, Effect of PM ~2.5~ exposure on renal D~1~R expression (G) and phosphorylation (H) in SD rats. Renal cortical membranes were prepared in SD rats exposed to PM ~2.5~ or vehicle for 8 weeks. D~1~R phosphorylation was normalized by total D~1~R expression (n=10 in each group). I and J, Effect of PM ~2.5~ exposure on renal G‐protein--coupled receptor kinase 4 (GRK4) mRNA (I) and protein (J) expressions in SD rats (n=10 in each group). \**P*\<0.0001 vs control rats, ^\#^ *P*\<0.0001 vs PM ~2.5~‐H group.](JAH3-7-e007185-g001){#jah32865-fig-0001}

Because of the important role of the dopamine receptor on sodium excretion, we also determined the effect of fenoldopam, a D~1~‐like receptor agonist, on sodium excretion. Consistent with previous reports,[41](#jah32865-bib-0041){ref-type="ref"}, [42](#jah32865-bib-0042){ref-type="ref"} fenoldopam induced natriuresis (Figure [1](#jah32865-fig-0001){ref-type="fig"}E) and diuresis (Figure [1](#jah32865-fig-0001){ref-type="fig"}F) in SD rats. However, after the treatment of SD rats by PM~2.5~ for 8 weeks, the fenoldopam‐induced natriuresis and diuresis were significantly decreased (Figure [1](#jah32865-fig-0001){ref-type="fig"}E and [1](#jah32865-fig-0001){ref-type="fig"}F). Moreover, the higher dose of PM~2.5~ worsened the D~1~ receptor--mediated sodium excretion to a higher degree compared with the lower dose of PM~2.5~ (Figure [1](#jah32865-fig-0001){ref-type="fig"}E and [1](#jah32865-fig-0001){ref-type="fig"}F). Our previous studies indicated that hyperphosphorylation of D~1~ receptor leads to the dysfunction of the renal D~1~ receptor, which is ascribed to the higher GRK4 expression and activity in spontaneously hypertensive rats or hypertensive patients.[17](#jah32865-bib-0017){ref-type="ref"}, [18](#jah32865-bib-0018){ref-type="ref"}, [19](#jah32865-bib-0019){ref-type="ref"}, [20](#jah32865-bib-0020){ref-type="ref"} Our additional study found that D~1~ receptor expression was lower and GRK4 expression and D~1~ receptor phosphorylation were higher in PM~2.5~‐treated SD rats. The degrees of change were greater with the higher dose of PM~2.5~ than the lower dose (Figure [1](#jah32865-fig-0001){ref-type="fig"}G through [1](#jah32865-fig-0001){ref-type="fig"}J), indicating GRK4 might be involved in the dysfunction of D~1~ receptor in PM~2.5~‐induced hypertension.

Role of GRK4 on PM~2.5~‐Impaired D~1~ Receptor Expression and Function in RPT Cells {#jah32865-sec-0025}
-----------------------------------------------------------------------------------

We used RPT cells to uncover the mechanism of PM~2.5~‐induced hypertension. We first determined the optimal concentration of PM~2.5~ required, and it showed that 200 μg/mL PM~2.5~ decreased RPT cell viability; PM~2.5~ concentrations from 10 to 100 μg/mL had no effect (Figure [2](#jah32865-fig-0002){ref-type="fig"}A). Therefore, we used 10 and 100 μg/mL as lower and higher concentrations, respectively, in the in vitro study.

![Effect of fine particulate matter (PM ~2.5~) exposure in in vitro study in renal proximal tubule (RPT) cells. A, Effect of PM ~2.5~ exposure on cell viability in RPT cells. Cell viability was assayed using Cell Counting Kit‐8 after exposure to vehicle (distilled water \[dH~2~O\]) or PM ~2.5~ for 24 hours. \**P*\<0.0001 vs control (n=9 in each group). B and C, Effect of PM ~2.5~ exposure on Na^+^‐K^+^‐ATPase activity in RPT cells. The cells were treated with PM ~2.5~ or vehicle (dH ~2~O) for 24 hours. Results are expressed as percentage change of control (B). \**P*\<0.0001 vs nonfenoldopam treatment in each group, ^\#^ *P*\<0.0001 vs control without fenoldopam and PM ~2.5~ treatment (n=10 in each group). C showed the fenoldopam‐induced reduction of Na^+^‐K^+^‐ATPase activity in each group. \**P*\<0.0001 vs control in C (n=10 in each group). D and E, Effect of PM ~2.5~ exposure on dopamine D~1~ receptor (D~1~R) protein expression (D) and serine phosphorylation (E) in RPT cells. RPT cells were exposed with 10 or 100 μg/mL concentration of PM ~2.5~ for 24 hours. Results were expressed as ratio of D~1~R phosphorylation/total D~1~R expression. \**P*\<0.05 vs control, ^\#^ *P*\<0.05 vs PM ~2.5~‐H group (n=9 in each group). F and G, Effect of PM ~2.5~ exposure on G‐protein--coupled receptor kinase 4 (GRK4) mRNA (F) and protein (G) expressions in RPT cells. RPT cells were exposed with 10 or 100 μg/mL concentration of PM ~2.5~ for 24 hours. \**P*\<0.01 vs control, ^\#^ *P*\<0.05 vs PM ~2.5~‐H group (n=9 in each group).](JAH3-7-e007185-g006){#jah32865-fig-0002}

Consistent with previous research findings,[43](#jah32865-bib-0043){ref-type="ref"}, [44](#jah32865-bib-0044){ref-type="ref"} the selective D~1~ receptor agonist fenoldopam caused an inhibition of the Na^+^‐K^+^‐ATPase activity, achieving a maximum of ≈30% in the control rats. With PM~2.5~ exposure, the basal Na^+^‐K^+^‐ATPase activity was increased and the fenoldopam‐mediated inhibitory effects on Na^+^‐K^+^‐ATPase activity were reduced (Figure [2](#jah32865-fig-0002){ref-type="fig"}B and [2](#jah32865-fig-0002){ref-type="fig"}C). Moreover, we also found that, compared with control, PM~2.5~‐treated cells had lower D~1~ receptor expression and higher D~1~ receptor phosphorylation (Figure [2](#jah32865-fig-0002){ref-type="fig"}D and [2](#jah32865-fig-0002){ref-type="fig"}E) and GRK4 expression (Figure [2](#jah32865-fig-0002){ref-type="fig"}F and [2](#jah32865-fig-0002){ref-type="fig"}G).

To further clarify the role of GRK4 on the Na^+^‐K^+^‐ATPase activity after PM~2.5~ exposure, we used a specific GRK4 siRNA to decrease the expression of GRK4 (Figure [3](#jah32865-fig-0003){ref-type="fig"}A and [3](#jah32865-fig-0003){ref-type="fig"}B). Downregulation of GRK4 by the siRNA reduced the increase in the basal Na^+^‐K^+^‐ATPase activity and reversed the inhibitory effect of fenoldopam on Na^+^‐K^+^‐ATPase activity in PM~2.5~‐treated cells (Figure [3](#jah32865-fig-0003){ref-type="fig"}C and [3](#jah32865-fig-0003){ref-type="fig"}D). Moreover, the decreased D~1~ receptor expression (Figure [3](#jah32865-fig-0003){ref-type="fig"}E) and increased D~1~ receptor phosphorylation (Figure [3](#jah32865-fig-0003){ref-type="fig"}F) by PM~2.5~ were also reversed after GRK4 siRNA treatment in RPT cells.

![Role of G‐protein--coupled receptor kinase 4 (GRK4) on fine particulate matter (PM ~2.5~)--mediated impairment in renal proximal tubule (RPT) cells. A and B, Effect of GRK4 small‐interfering RNA (siRNA) on GRK4 expression. RPT cells were transfected with siRNA for 24 hours. GRK4 mRNA expression (A) and protein expression (B) were determined by quantitative polymerase chain reaction or immunoblotting. \**P*\<0.0001 vs control (n=10 in each group). C and D, Effect of GRK4 siRNA on Na^+^‐K^+^‐ATPase activity in RPT cells. After transfection with GRK4 siRNA for 24 hours, RPT cells were treated with PM ~2.5~ (100 μg/mL) or vehicle (distilled water) for another 24 hours. Na^+^‐K^+^‐ATPase activity was checked with or without the presence of fenoldopam. C, Results are expressed as percentage change of control. \**P*\<0.0001 vs PM ~2.5~ only (100 μg/mL), ^\#^ *P*\<0.0001 vs nonfenoldopam treatment in each group (n=10 in each group). D, Fenoldopam‐induced reduction of Na^+^‐K^+^‐ATPase activity in each group. \**P*\<0001 vs fenoldopam only, ^\#^ *P*\<0001 vs siRNA treatment (n=10 in each group). E and F, Effect of GRK4 siRNA on dopamine D~1~ receptor (D~1~R) phosphorylation and GRK4 protein expressions in RPT cells exposed to PM ~2.5~ (100 μg/mL). After transfection with GRK4 siRNA for 24 hours, D~1~R phosphorylation (E) and GRK4 expression (F) were checked in PM ~2.5~‐exposed RPT cells. \**P*\<0001 vs control, ^\#^ *P*\<0001 vs PM ~2.5~ only (100 μg/mL) (n=10 in each group).](JAH3-7-e007185-g005){#jah32865-fig-0003}

Role of ROS in PM~2.5~‐Induced Hypertension and Impaired Renal Function {#jah32865-sec-0026}
-----------------------------------------------------------------------

ROS has been reported to play a role in the dysfunction of D~1~ receptor in obese Zucker rats,[23](#jah32865-bib-0023){ref-type="ref"}, [26](#jah32865-bib-0026){ref-type="ref"}, [27](#jah32865-bib-0027){ref-type="ref"} and there is evidence showing that PM~2.5~ increases inflammation and ROS production.[28](#jah32865-bib-0028){ref-type="ref"}, [31](#jah32865-bib-0031){ref-type="ref"} Therefore, we wondered whether ROS is involved in the pathogenesis of PM~2.5~‐induced hypertension. We first measured ROS production in the PM~2.5~‐ and vehicle‐treated (control) rats. We found that plasma malondialdehyde levels were higher, whereas SOD and glutathione peroxidase levels were lower, in PM~2.5~‐treated rats versus the vehicle‐treated rats (Figure [4](#jah32865-fig-0004){ref-type="fig"}A through [4](#jah32865-fig-0004){ref-type="fig"}C). The dichloro‐dihydro‐fluorescein diacetate staining showed ROS level was significantly increased after PM~2.5~ treatment in both RPT alone and RPT/THP‐1 cocultured cells, whereas the extent of ROS elevation was much higher in RPT/THP‐1 cocultured cells than those in RPT cells alone with PM~2.5~ treatment (Figure [S4](#jah32865-sup-0001){ref-type="supplementary-material"}).

![Effect of fine particulate matter (PM~2.5~) exposure on oxidative stress and c‐Myc expression in Sprague‐Dawley (SD) rats. SD rats were exposed with lower (3 μg PM ~2.5~ per time \[PM ~2.5~‐L\]) or higher (30 μg PM ~2.5~ per time \[PM ~2.5~‐H\]) dosage of PM ~2.5~ for 8 weeks. Plasma superoxide dismutase (SOD) (A), glutathione peroxidase (GSH‐Px) (B), and malondialdehyde (MDA) (C) levels, and c‐Myc mRNA (D) and protein (E) expressions were determined in those rats. \**P*\<0.005 vs control rats, ^\#^ *P*\<0.001 vs PM ~2.5~‐H group (n=12 in each group).](JAH3-7-e007185-g002){#jah32865-fig-0004}

It is known that c‐Myc is a transcription factor for GRK4, and there is evidence that ROS increases c‐Myc expression.[45](#jah32865-bib-0045){ref-type="ref"}, [46](#jah32865-bib-0046){ref-type="ref"}, [47](#jah32865-bib-0047){ref-type="ref"} We, therefore, tried to determine whether PM~2.5~ increased GRK4 via the c‐Myc pathway. Results showed that c‐Myc expression was higher in PM~2.5~‐treated than control cells (Figure [4](#jah32865-fig-0004){ref-type="fig"}D and [4](#jah32865-fig-0004){ref-type="fig"}E), indicating that PM~2.5~ might increase GRK4 expression via an increased c‐Myc expression.

To determine directly the role of ROS in PM~2.5~‐induced hypertension, tempol, an SOD mimetic, was used to treat PM~2.5~ rats, which were exposed to PM~2.5~ for 8 weeks. After tempol (1.0 mmol/L in drinking water[24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"}) treatment for 3 weeks, the increased malondialdehyde and the decreased SOD/ glutathione peroxidase levels were recovered in PM~2.5~ rats (Figure [5](#jah32865-fig-0005){ref-type="fig"}A through [5](#jah32865-fig-0005){ref-type="fig"}C). Furthermore, the sodium excretion was increased, and blood pressure was lowered, in PM~2.5~ rats (Figure [5](#jah32865-fig-0005){ref-type="fig"}D through [5](#jah32865-fig-0005){ref-type="fig"}G), and the fenoldopam‐induced natriuresis and diuresis were also recovered in PM~2.5~‐exposed rats (Figure [5](#jah32865-fig-0005){ref-type="fig"}H and [5](#jah32865-fig-0005){ref-type="fig"}I), accompanied with a recovered renal D~1~ receptor expression and phosphorylation and GRK4 expression (Figure [5](#jah32865-fig-0005){ref-type="fig"}J and [5](#jah32865-fig-0005){ref-type="fig"}K). It is interesting to find that the renal c‐Myc expression is also reduced after treatment with tempol in PM~2.5~‐exposed rats (Figure [5](#jah32865-fig-0005){ref-type="fig"}L and [5](#jah32865-fig-0005){ref-type="fig"}M), which further indicated the role of c‐Myc in the PM~2.5~‐induced hypertension.

![Effect of tempol on blood pressure and sodium excretion in Sprague‐Dawley (SD) rats exposed to fine particulate matter (PM ~2.5~). SD rats exposed to PM ~2.5~ were treated with tempol for 3 weeks. Plasma superoxide dismutase (SOD) (A), glutathione peroxidase (GSH‐Px) (B), and malondialdehyde (MDA) (C) levels were checked in those rats (n=12 in each group). The blood pressure (D and E) and sodium excretion (F and G) were recorded (n=12 in each group). Moreover, the fenoldopam‐mediated urinary flow rate (H) and urine sodium excretion rate (I), G‐protein--coupled receptor kinase 4 (GRK4) expression (J), and dopamine D~1~ receptor (D~1~R) phosphorylations (K), as well as c‐Myc mRNA (L) and protein expressions (M) were checked (n=10 in each group). DBP indicates diastolic blood pressure; PM~2.5~‐H, 30 μg PM ~2.5~ per time; and SBP, systolic blood pressure. \**P*\<0.0001 vs control rats, ^\#^ *P*\<0.0001 vs PM ~2.5~‐H rats.](JAH3-7-e007185-g003){#jah32865-fig-0005}

Consistent with the in vivo study, PM~2.5~ increased malondialdehyde and ROS concentrations in the supernatants from RPT cells, which were normalized by tempol (200 μmol/L) treatment (Figure [6](#jah32865-fig-0006){ref-type="fig"}A and [6](#jah32865-fig-0006){ref-type="fig"}B), whereas the high expression of c‐Myc was decreased (Figure [6](#jah32865-fig-0006){ref-type="fig"}C and [6](#jah32865-fig-0006){ref-type="fig"}D). Moreover, tempol reversed the fenoldopam‐mediated inhibitory effects on Na^+^‐K^+^‐ATPase activity in PM~2.5~‐treated RPT cells (Figure [6](#jah32865-fig-0006){ref-type="fig"}E and [6](#jah32865-fig-0006){ref-type="fig"}F). Meanwhile, the lowered renal D~1~ receptor expression and the upregulated renal D~1~ receptor phosphorylation and GRK4 expression were normalized by tempol in PM~2.5~‐treated RPT cells (Figure [6](#jah32865-fig-0006){ref-type="fig"}G and [6](#jah32865-fig-0006){ref-type="fig"}H).

![Effect of tempol on Na^+^‐K^+^‐ATPase activity and G‐protein--coupled receptor kinase 4(GRK4) expression in renal proximal tubule (RPT) cells exposed to fine particulate matter (PM ~2.5~). RPT cells exposed to vehicle (control) or PM ~2.5~ were treated with tempol (200 μmol/L) for 24 hours. Superoxide dismutase (SOD) (A) and malondialdehyde (MDA) levels (B) were quantified in the cell culture medium supernatant. \**P*\<0.0001 vs control, ^\#^ *P*\<0.0001 vs PM ~2.5~ only (100 μg/mL) (n=12 in each group). c‐Myc mRNA (C) and protein (D) expressions were checked in those cells. \**P*\<0.0001 vs control, ^\#^ *P*\<0.0001 vs PM ~2.5~ only (100 μg/mL) (n=10 in each group). Moreover, the Na^+^‐K^+^‐ATPase activity (E and F) and GRK4 expression (G) and dopamine D~1~ receptor (D~1~R) phosphorylations (H) were tested in those cells. \**P*\<0.05 vs control, ^\#^ *P*\<0.001 vs PM ~2.5~ treated (100 μg/mL) (n=10 in each group).](JAH3-7-e007185-g004){#jah32865-fig-0006}

Discussion {#jah32865-sec-0027}
==========

Exposure to ambient particulate matter has been associated with increased hospital admission and mortality for cardiovascular diseases.[4](#jah32865-bib-0004){ref-type="ref"}, [6](#jah32865-bib-0006){ref-type="ref"}, [7](#jah32865-bib-0007){ref-type="ref"}, [29](#jah32865-bib-0029){ref-type="ref"} However, the mechanisms are not completely understood. Hypertension is an established risk factor for cardiovascular disease and may be implicated in the association between ambient particulate matter and cardiovascular morbidity and mortality.[11](#jah32865-bib-0011){ref-type="ref"} Epidemiological studies have shown that traffic[4](#jah32865-bib-0004){ref-type="ref"}, [48](#jah32865-bib-0048){ref-type="ref"} or household[49](#jah32865-bib-0049){ref-type="ref"}, [50](#jah32865-bib-0050){ref-type="ref"}, [51](#jah32865-bib-0051){ref-type="ref"} PM~2.5~ exposure can increase blood pressure in both the short‐ and long‐term. Many animal experimental studies have validated the view of the above‐mentioned evidence‐based‐studies.[8](#jah32865-bib-0008){ref-type="ref"}, [31](#jah32865-bib-0031){ref-type="ref"}, [52](#jah32865-bib-0052){ref-type="ref"}, [53](#jah32865-bib-0053){ref-type="ref"}, [54](#jah32865-bib-0054){ref-type="ref"} In this study, PM~2.5~ was confirmed to be associated with increased blood pressure, and the blood pressure was positively correlated with the exposure dose within a certain range. Even a lower concentration of PM~2.5~ exposure can cause an increased blood pressure.

Although the mechanisms of PM~2.5~‐induced hypertension are not clear, some mechanisms, including oxidative stress, inflammatory reaction, changes in sympathetic nerve activity, DNA damage, and apparent genetic changes, have been reported to be involved in the pathogenesis of hypertension.[6](#jah32865-bib-0006){ref-type="ref"}, [8](#jah32865-bib-0008){ref-type="ref"}, [10](#jah32865-bib-0010){ref-type="ref"}, [11](#jah32865-bib-0011){ref-type="ref"}, [12](#jah32865-bib-0012){ref-type="ref"} Our present study and others show the role of impaired sodium excretion in PM~2.5~‐induced hypertension. It is known that sodium excretion is regulated by numerous hormones and humoral factors, including dopamine. Renal dopamine, independent of renal nerves, plays an important role in maintaining sodium homeostasis and blood pressure regulation, especially during moderately increased sodium intake. Under conditions of moderate sodium excess, the renal dopaminergic system, mainly the D~1~R, is responsible for \>50% of renal sodium excretion.[13](#jah32865-bib-0013){ref-type="ref"} Abnormalities in renal dopamine and D~1~R response to an increased sodium load have been implicated in the diminished natriuretic response and increase in blood pressure in hypertensive patients and rodents.[13](#jah32865-bib-0013){ref-type="ref"}, [14](#jah32865-bib-0014){ref-type="ref"}, [15](#jah32865-bib-0015){ref-type="ref"}, [16](#jah32865-bib-0016){ref-type="ref"}, [23](#jah32865-bib-0023){ref-type="ref"} The impaired D~1~R function is ascribed to the hyperphosphorylation, which leads to the uncoupling of D~1~R with G protein.[13](#jah32865-bib-0013){ref-type="ref"}, [14](#jah32865-bib-0014){ref-type="ref"}, [15](#jah32865-bib-0015){ref-type="ref"}, [16](#jah32865-bib-0016){ref-type="ref"} Our previous study found that the hyperphosphorylated D~1~R is caused by a constitutively increased GRK4 activity and expression in hypertension.[13](#jah32865-bib-0013){ref-type="ref"}, [18](#jah32865-bib-0018){ref-type="ref"}, [19](#jah32865-bib-0019){ref-type="ref"}, [20](#jah32865-bib-0020){ref-type="ref"}, [21](#jah32865-bib-0021){ref-type="ref"} Consistent with hypertension, our present study found that D~1~R‐mediated diuresis and natriuresis are impaired in PM~2.5~‐exposed rats, accompanied with D~1~R hyperphosphorylation. The increased phosphorylation of D~1~R is ascribed to GRK4, because in both in vivo and in vitro studies, GRK4 expression is increased because of PM~2.5~ exposure; after downregulation of GRK4 with siRNA, the impaired inhibitory effect of D~1~R on Na^+^‐K^+^‐ATPase activity was reversed in RPT cells exposed to PM~2.5~. Thus, the current studies support the notion that GRK4 is involved in the impaired function of renal D~1~R in PM~2.5~‐exposed hypertension.

Many studies have indicated that both hypertensive patients and animals have decreased antioxidant capacity and produce excessive amounts of ROS.[27](#jah32865-bib-0027){ref-type="ref"}, [55](#jah32865-bib-0055){ref-type="ref"}, [56](#jah32865-bib-0056){ref-type="ref"}, [57](#jah32865-bib-0057){ref-type="ref"} Antioxidant treatment could mitigate the production of ROS and further increase antioxidant capacity, such as SOD and glutathione in plasma and tissue, consequently decreasing the blood pressure in hypertensive animal models. PM~2.5~ is known to increase serum tumor necrosis factor‐α level and stimulate macrophages to generate ROS and enhance oxidative stress.[28](#jah32865-bib-0028){ref-type="ref"}, [29](#jah32865-bib-0029){ref-type="ref"}, [30](#jah32865-bib-0030){ref-type="ref"}, [31](#jah32865-bib-0031){ref-type="ref"}, [33](#jah32865-bib-0033){ref-type="ref"}, [58](#jah32865-bib-0058){ref-type="ref"}, [59](#jah32865-bib-0059){ref-type="ref"}, [60](#jah32865-bib-0060){ref-type="ref"} Multiple studies have shown that an impaired intrarenal D~1~R signaling in hypertension can cause or be caused by oxidative stress.[24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"}, [26](#jah32865-bib-0026){ref-type="ref"}, [27](#jah32865-bib-0027){ref-type="ref"}, [61](#jah32865-bib-0061){ref-type="ref"} Our present study found that tempol treatment would reduce ROS, lower blood pressure, and reverse the impaired D~1~R‐mediated natriuresis and diuresis in PM~2.5~‐exposed rats.

As stated previously and in other reports, ROS is related to the regulation of GRK4 on D~1~R expression and function and tempol has been shown to reduce GRK4 level, restore D~1~R expression and function, and normalize blood pressure by decreasing oxidative stress.[22](#jah32865-bib-0022){ref-type="ref"}, [24](#jah32865-bib-0024){ref-type="ref"}, [25](#jah32865-bib-0025){ref-type="ref"} However, the molecular mechanisms involved are not well understood. c‐Myc, a human homolog of the avian myelocytomatosis viral oncogene v‐Myc, is involved in cancer progression, which has been implicated in hypertrophy and fibrosis of the heart, atherosclerosis, and hypertension.[45](#jah32865-bib-0045){ref-type="ref"}, [46](#jah32865-bib-0046){ref-type="ref"}, [47](#jah32865-bib-0047){ref-type="ref"} c‐Myc was shown to bind to the promoter region of GRK4 in Burkitt lymphoma cells. Gildea et al found c‐Myc may be involved in the increase in blood pressure in hypertension that is mediated by increased activity of the renin‐angiotensin system and decreased activity of the renal dopaminergic system.[45](#jah32865-bib-0045){ref-type="ref"} Many other studies also report that ROS increased c‐Myc expression.[46](#jah32865-bib-0046){ref-type="ref"}, [47](#jah32865-bib-0047){ref-type="ref"} Our present study found that ROS associated with increased c‐Myc levels and increased GRK4 expression in PM~2.5~‐exposed rats and cells.

In the present study, the particulate sampling method is universally accepted,[32](#jah32865-bib-0032){ref-type="ref"}, [33](#jah32865-bib-0033){ref-type="ref"}, [34](#jah32865-bib-0034){ref-type="ref"} and we performed a scanning electron microscope analysis of the samples to determine the reliability of the samples. To ensure the success of the exposure model, we also performed a hematoxylin‐eosin stain of the lung after the rats were euthanized, and a light microscope detection confirmed the presence of PM~2.5~ in the lung tissue. According to the World Health Organization\'s Air Quality Guideline, an annual mean PM~2.5~ concentration of 35 μg/m^3^ was selected as the level 1 interim target, which corresponds to the highest mean concentrations reported in studies of long‐term health effects. This level has been shown to be associated with significant mortality in the developed world.[62](#jah32865-bib-0062){ref-type="ref"} For this reason, in this study, the rats received 2 dosages of PM~2.5~. A lower dosage represented 35 μg/m^3^ per 24 hours PM~2.5~, whereas the higher dosage represented 350 μg/m^3^ per 24 hours PM~2.5~ in the air.

In summary, our study shows direct evidence supporting the hypothesis that PM~2.5~ causes hypertension and, for first time, links the dysfunction of the renal D~1~R to the hypertension attributable to PM~2.5~ exposure. Increased oxidative stress, associated with increased GRK4 levels, impairs renal D~1~R function and leads to hypertension. Restoration of D~1~R function by antioxidants may be a therapeutic target for PM~2.5~‐caused hypertension.
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**Figure S1.** Scanning electron microscopy analysis of PM~2.5~ samples.

**Figure S2.** The flowchart of animal studies.

**Figure S3.** Lung histology from control and exposed rats.

**Figure S4.** The ROS generation in RPT cells after PM~2.5~ exposure.
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